Lindus

📍 Boston, United States👥 211 employees💰 Last funded Nov 2024
Research Services🌐 lindushealth.com
Website LinkedIn
Lindus is an Accountable Research Organization, engineered to give biotech and pharmaceutical sponsors confidence and control to generate clinical data on time and on budget. In the last 3 years, Lindus has executed over 45 full-scope trials across cardiometabolic, respiratory, psychiatry, dermatology, womens health, and diagnostics. Behind each study is an integrated model spanning feasibility, central enrollment infrastructure, and flexible site models. Trials run on Citrus™, an AI-native trial operating system, and are governed by performance-based contracts with milestone-based payments. 82% of Lindus executed trials completed enrollment on or ahead of our proposed timeline. The company is backed by Dr. Bob Langer, Peter Thiel, and Dr. Tim Garnett.
11
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

11 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
United Kingdom
7
Germany
2
Sweden
1
United States
1
Investor activity2021–2024 · investors recorded per year
20214202212023420242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Lindus?
Lindus has 11 investors on record on gritt.io.
When did Lindus last raise funding?
The most recent investment in Lindus recorded on gritt.io was in November 2024.
What industry is Lindus in?
Lindus operates in Research Services. Find similar Research Services investors on gritt.io.
Where is Lindus based?
Lindus is headquartered in Boston, United States.